HOME › DRUGS › LAMOTRIGINE
ACTIVE SUBSTANCE / INN

LAMOTRIGINE

Brand name(s): LAMICTAL XR, LAMICTAL, SUBVENITE, LAMOTRIGINE, LAMICTAL CD, LAMICTAL ODT
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA020241
NDA218879
ACTIVE SUBSTANCE
Lamotrigine
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, SMITHKLINE BEECHAM, OWP PHARMS
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LAMOTRIGINEANDA076928WATSON LABSPrescription
LAMOTRIGINEANDA203370TORRENTDiscontinued
LAMOTRIGINEANDA077757CARACONone (Tentative Approval)
LAMICTAL XRNDA022509SMITHKLINE BEECHAMPrescription
LAMICTAL CDNDA020764GLAXOSMITHKLINE LLCDiscontinued
LAMICTAL CDNDA020764GLAXOSMITHKLINE LLCPrescription
SUBVENITENDA218879OWP PHARMSPrescription
LAMICTALNDA020241GLAXOSMITHKLINE LLCPrescription
LAMICTALNDA020241GLAXOSMITHKLINE LLCDiscontinued
LAMICTAL ODTNDA022251GLAXOSMITHKLINE LLCPrescription

FULL INTELLIGENCE ON LAMOTRIGINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →